| Cardiac resynchronisation therapy: non responders or non progressors? | Don't select the wrong patient. | Maurizio Gasparini (IT) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Cardiac resynchronisation therapy: non responders or non progressors? | Is lead placement a real issue? | Ignacio Fernandez Lozano (ES) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Cardiac resynchronisation therapy: non responders or non progressors? | Don't forget to optimise the device programming. | Ali Oto (Turkey) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Cardiac resynchronisation therapy: non responders or non progressors? | What is going to be next? | Christophe Leclercq (FR) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Syncope in cardiology practice | An analysis of pathophysiologies. | Richard Sutton (UK) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Syncope in cardiology practice | Syncope evaluation: the role of syncope clinics. | Michele Brignole (IT) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Syncope in cardiology practice | Syncope in patients without heart disease. | Angel Moya I Mitjans (ES) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Syncope in cardiology practice | Falls in the elderly. Diagnostic and therapeutic approach. | Stylianos Tzeis (GR) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Atrial fibrillation ablation. Optimal approaches in 2010 | Patients with paroxysmal atrial fibrillation. | Eric N Prystowsky (US) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Atrial fibrillation ablation. Optimal approaches in 2010 | Patients with persistent/permanent atrial fibrillation. | Carlo Pappone (IT) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Atrial fibrillation ablation. Optimal approaches in 2010 | Repeat procedures: the best approach. | Gerhard Hindricks (DE) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Atrial fibrillation ablation. Optimal approaches in 2010 | Surgical approach to paroxysmal/persistent atrial fibrillation. | Ralph J Damiano (US) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| The new ESC Guidelines | Atrial fibrillation. | John Camm (UK) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Cardiac resynchronisation therapy: optimising patient selection with imaging | Assessing mechanical dyssynchrony: echo is still alive!!! | Erwan Donal (FR) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| Cardiac resynchronisation therapy: optimising patient selection with imaging | Do not forget the coronary sinus anatomy. | Christopher Piorkowski (DE) | Arrhythmias / Pacing / Resynchronisation | 29 Aug 2010 |
| The new ESC Guidelines | Myocardial revascularisation (ESC/EACTS). | William Wijns (BE) | Cardiovascular surgery | 29 Aug 2010 |
| Revascularisation in coronary artery disease in 2010 | Multivessel and left main disease: indications for surgical and percutaneous intervention. | William Wijns (BE) | Cardiovascular surgery | 29 Aug 2010 |
| Revascularisation in coronary artery disease in 2010 | Ways to improve coronary artery bypass grafting outcomes. | Volkmar Falk (CH) | Cardiovascular surgery | 29 Aug 2010 |
| Revascularisation in coronary artery disease in 2010 | Peri-operative pharmacotherapy in high-risk unstable syndromes. | Jean-Pierre Bassand (FR) | Cardiovascular surgery | 29 Aug 2010 |
| Revascularisation in coronary artery disease in 2010 | Prognostic impact of bleeding and transfusion. | Lucia Torracca (IT) | Cardiovascular surgery | 29 Aug 2010 |
| The new ESC Guidelines | Grown-up congenital heart disease. | Helmut Baumgartner (DE) | Congenital heart disease / Pediatric cardiology | 29 Aug 2010 |
| Management of sources of embolism: the role of echocardiography | The neurologist's point of view. | Jose Manuel Ferro (PT) | Echocardiography / Doppler | 29 Aug 2010 |
| Management of sources of embolism: the role of echocardiography | Permanent foramen ovale: when to close? | Pierre Amarenco (FR) | Echocardiography / Doppler | 29 Aug 2010 |
| Management of sources of embolism: the role of echocardiography | Atherosclerosis of the aorta. | Arturo Evangelista Masip (ES) | Echocardiography / Doppler | 29 Aug 2010 |
| Hot Line I - Heart failure and left ventricular dysfunction | The STAR Heart Study: the acute and long-term effect of intracoronary stem cell transplantation in 191 patients with chronic heart failure | Bodo-Eckehard Strauer (DE) | Heart failure / LV dysfunction | 29 Aug 2010 |
| Hot Line I - Heart failure and left ventricular dysfunction | Discussant: The STAR Heart Study: the acute and long-term effect of intracoronary stem cell transplantation in 191 patients with chronic heart failure | Francisco Fernandez-Aviles (ES) | Heart failure / LV dysfunction | 29 Aug 2010 |
| Hot Line I - Heart failure and left ventricular dysfunction | PEARL HF: Multicenter, randomized, double-blind, placebo-controlled, parallel-group, multiple-dose study to evaluate the effects of RLY5016 in heart failure patients | Bertram Pitt (US) | Heart failure / LV dysfunction | 29 Aug 2010 |
| Hot Line I - Heart failure and left ventricular dysfunction | Discussant: PEARL HF: Multicenter, randomized, double-blind, placebo-controlled, parallel-group, multiple-dose study to evaluate the effects of RLY5016 in heart failure patients | Henry J Dargie (UK) | Heart failure / LV dysfunction | 29 Aug 2010 |
| Hot Line I - Heart failure and left ventricular dysfunction | Discussant: SHIFT: Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction | Inder Anand (US) | Heart failure / LV dysfunction | 29 Aug 2010 |
| Meet the Trialist I - SHIFT | SHIFT: Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction | Michel Komajda (FR) | Heart failure / LV dysfunction | 29 Aug 2010 |
| The new ESC Guidelines | 2010 focused update of ESC Guidelines on device therapy in heart failure. | Kenneth Dickstein (NO) | Heart failure / LV dysfunction | 29 Aug 2010 |
| Management of acute heart failure | Acutely decompensated chronic ischaemic heart failure with pulmonary congestion. | Marco Metra (IT) | Heart failure / LV dysfunction | 29 Aug 2010 |
| Management of acute heart failure | Acute heart failure with hypotension and renal dysfunction. | Alexandre Mebazaa (FR) | Heart failure / LV dysfunction | 29 Aug 2010 |
| Management of acute heart failure | What do the Guidelines say? | Jose Lopez-Sendon (ES) | Heart failure / LV dysfunction | 29 Aug 2010 |
| Hypertension guidelines - are there global differences and are they important? | The view of the British Hypertension Society. | Adrian Jb Brady (UK) | Hypertension | 29 Aug 2010 |
| Hypertension guidelines - are there global differences and are they important? | Asian Pacific Society - the view from down under. | John P Chalmers (AU) | Hypertension | 29 Aug 2010 |
| Drug-eluting stents: from revolution to evolution | Current limitations. | Eric Eeckhout (CH) | Interventional cardiology | 29 Aug 2010 |
| Drug-eluting stents: from revolution to evolution | Optimal antiplatelet therapy. | Manel Sabate Tenas (ES) | Interventional cardiology | 29 Aug 2010 |
| Drug-eluting stents: from revolution to evolution | Cost-effectiveness. | David J Cohen (US) | Interventional cardiology | 29 Aug 2010 |
| Drug-eluting stents: from revolution to evolution | New drug-eluting stents. | Alexandre Abizaid (BR) | Interventional cardiology | 29 Aug 2010 |
| Clinical Trial Update I | ISAR TEST 4: Two-year Clinical Outcomes from a Randomized Trial of Biodegradable Polymer Drug-Eluting Stents Versus Permanent Polymer Cypher and Xience Drug-Eluting Stents | Robert Byrne (DE) | Interventional cardiology | 29 Aug 2010 |
| Clinical Trial Update I | Discussant: ISAR TEST 4: Two-year Clinical Outcomes from a Randomized Trial of Biodegradable Polymer Drug-Eluting Stents Versus Permanent Polymer Cypher and Xience Drug-Eluting Stents | Jean Marco (FR) | Interventional cardiology | 29 Aug 2010 |
| Therapeutic options in chronic refractory angina | Scale of the problem. | Anselm Kai Gitt (DE) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Therapeutic options in chronic refractory angina | Spinal cord stimulation. | Mats Borjesson (SE) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Therapeutic options in chronic refractory angina | Enhanced external counterpulsation. | Ozlem Soran (US) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Therapeutic options in chronic refractory angina | Can interventional cardiologists do better? | Jens Kastrup (DK) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Therapeutic challenges in octogenarians with ischaemic heart disease | Prevention. | Dan Gaita (RO) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Therapeutic challenges in octogenarians with ischaemic heart disease | Fibrinolysis. | Hector Bueno (ES) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Therapeutic challenges in octogenarians with ischaemic heart disease | Percutaneous interventions. | Nicolas Danchin (FR) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Hot Line I - Heart failure and left ventricular dysfunction | HEBE III: A single dose of erythropoietin in ST-elevation myocardial infarction | Adriaan Voors (NL) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Hot Line I - Heart failure and left ventricular dysfunction | Discussant: HEBE III: A single dose of erythropoietin in ST-elevation myocardial infarction | Piotr Ponikowski (PL) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Clinical Trial Update I | MULTI STRATEGY: 3-year Follow-up of the Comparison of Angioplasty with Infusion of Tirofiban or Abciximab and with Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial Infarction | Marco Valgimigli (IT) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Clinical Trial Update I | PLATO genetic substudy: Impact of CYP2C19 and ABCB1 single nucleotide polymorphisms (SNPs) on outcomes with ticagrelor and clopidogrel in acute coronary syndrome - a PLATO genetic substudy | Lars Wallentin (SE) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Clinical Trial Update I | Discussant: PLATO genetic substrudy: Impact of CYP2C19 and ABCB1 single nucleotide polymorphisms (SNPs) on outcomes with ticagrelor and clopidogrel in acute coronary syndrome - a PLATO genetic substudy | Kurt Huber (AT) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Meet the Trialist II - HEBE III | HEBE III: A Single Dose of Erythropoietin in ST-elevation Myocardial Infarction | Adriaan Voors (NL) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Innovations in imaging of coronary heart disease | New developments in myocardial perfusion imaging. | Roxy Senior (UK) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Anti-thrombotic therapy in acute coronary syndromes - difficult situations | Pretreatment in STEMI. | Christian Hamm (DE) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Anti-thrombotic therapy in acute coronary syndromes - difficult situations | NSTEMI - management strategy in a patient with an increased bleeding risk. | David Erlinge (SE) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Anti-thrombotic therapy in acute coronary syndromes - difficult situations | What do the Guidelines say? | Steen Dalby Kristensen (DK) | Ischaemia / ACS / infarction | 29 Aug 2010 |
| Infectious myocarditis and pericarditis | Viral myocarditis/pericarditis: pathogenesis. | Alida Lp Caforio (IT) | Myocardial-Pericardial disease | 29 Aug 2010 |
| Infectious myocarditis and pericarditis | How to diagnose viral infection of the heart and pericardium. | Sabine Pankuweit (DE) | Myocardial-Pericardial disease | 29 Aug 2010 |
| Infectious myocarditis and pericarditis | How to treat viral myocarditis. | Uwe Kuehl (DE) | Myocardial-Pericardial disease | 29 Aug 2010 |
| Infectious myocarditis and pericarditis | Bacterial infections of the myocardium and pericardium. | Petar Seferovic (Serbia) | Myocardial-Pericardial disease | 29 Aug 2010 |
| Innovations in imaging of coronary heart disease | Role of magnetic resonance imaging in the acute myocardial infarction. | Massimo Lombardi (IT) | Nuclear cardiology, CMR & CT | 29 Aug 2010 |
| Assessment of myocardial viability | Cases 1. | Hans-Marc Siebelink (NL) | Nuclear cardiology, CMR & CT | 29 Aug 2010 |
| Assessment of myocardial viability | Cases 2. | Heikki Ukkonen (FI) | Nuclear cardiology, CMR & CT | 29 Aug 2010 |
| Clinical Trial Update I | Discussant: CURE ACTIVE: Efficacy and Safety of Clopidogrel compared with Placebo according to CYP2C19 Genotype in over 6000 patients with Non-ST-elevation Acute Coronary Syndromes (CURE trial) and atrial fibrillation (ACTIVE trial) | Robert M Califf (US) | Pharmacology and pharmacotherapy | 29 Aug 2010 |
| Therapeutic challenges in octogenarians with ischaemic heart disease | Antiplatelet/anticoagulant treatment and risk of bleeding. | Freek Verheugt (NL) | Prevention and rehabilitation | 29 Aug 2010 |
| Hot Line I - Heart failure and left ventricular dysfunction | Discussant: ALPHA OMEGA: Effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients | Luigi Tavazzi (IT) | Prevention and rehabilitation | 29 Aug 2010 |
| Update on the management of dyslipidemias | Global cardiovascular risk: the role of lipids. | Ian Graham (Ireland) | Prevention and rehabilitation | 29 Aug 2010 |
| Update on the management of dyslipidemias | Plasma lipid control in Europe: recent data. | David Allan Wood (UK) | Prevention and rehabilitation | 29 Aug 2010 |
| Update on the management of dyslipidemias | Cardiovascular benefit of low-density lipoprotein lowering. | Terje Pedersen (NO) | Prevention and rehabilitation | 29 Aug 2010 |
| Update on the management of dyslipidemias | High-density lipoprotein and cardiovascular risk. | John Chapman (FR) | Prevention and rehabilitation | 29 Aug 2010 |
| Update on the management of dyslipidemias | Triglycerides and cardiovascular risk. | Marja-Riitta Taskinen (FI) | Prevention and rehabilitation | 29 Aug 2010 |
| Acute pulmonary embolism - 2010 | ESC Guidelines versus real-life diagnosis of acute pulmonary embolism - data from ZATPOL Registry. | Adam Torbicki (PL) | Pulmonary circulation | 29 Aug 2010 |
| Acute pulmonary embolism - 2010 | Largest ever - lessons from RIETE Registry of venous thromboembolism. | Manuel Monreal Bosch (ES) | Pulmonary circulation | 29 Aug 2010 |
| Acute pulmonary embolism - 2010 | PEITHO - the hope for 'intermediate-risk' patients. | Stavros V Konstantinides (GR) | Pulmonary circulation | 29 Aug 2010 |
| Acute pulmonary embolism - 2010 | ESC Guidelines on management of acute pulmonary embolism - is an update needed? | Arnaud Perrier (CH) | Pulmonary circulation | 29 Aug 2010 |
| Difficult aspects of aortic stenosis | Prognosis of patients with mild to moderate aortic stenosis. | Anne Bjorhovde Rossebo (NO) | Valvular disease | 29 Aug 2010 |
| Difficult aspects of aortic stenosis | Challenges in assessing aortic stenosis. | Catherine M Otto (US) | Valvular disease | 29 Aug 2010 |
| Difficult aspects of aortic stenosis | Low gradient severe aortic stenosis with normal left-ventricular ejection fraction: a disturbing clinical entity. | Jean-Luc Monin (FR) | Valvular disease | 29 Aug 2010 |
| Difficult aspects of aortic stenosis | Transcatheter aortic valve implantation update 2010. | Thierry Lefevre (FR) | Valvular disease | 29 Aug 2010 |
| Endocarditis: what's new in the guidelines? | Prevention and patient education. | Bernard David Prendergast (UK) | Valvular disease | 29 Aug 2010 |
| Endocarditis: what's new in the guidelines? | When to operate and how. | Manuel J Antunes (PT) | Valvular disease | 29 Aug 2010 |
| Endocarditis: what's new in the guidelines? | Neurological problems in patients with endocarditis. | Jose Alberto San Roman Calvar (ES) | Valvular disease | 29 Aug 2010 |
| Clinical Trial Update I | EVOLUTION: Clinical EValuation Of the Edwards Lifesciences percUTaneous mItral annulOplasty system for the treatment of mitral regurgitatioN | Jan Harnek (SE) | Valvular disease | 29 Aug 2010 |
| Clinical Trial Update I | Discussant: EVOLUTION: Clinical EValuation Of the Edwards Lifesciences percUTaneous mItral annulOplasty system for the treatment of mitral regurgitatioN | Manuel J Antunes (PT) | Valvular disease | 29 Aug 2010 |
| Clinical Trial Update I | SOURCE REGISTRY TAVI: Development of a risk score for transcatheter aortic valve implantation: 1-year outcomes from over 1,000 patients in the source registry | Olaf Wendler (UK) | Valvular disease | 29 Aug 2010 |
| Clinical Trial Update I | Discussant: SOURCE REGISTRY TAVI: Development of a risk score for transcatheter aortic valve implantation: 1-year outcomes from over 1,000 patients in the source registry | Gerhard Schuler (DE) | Valvular disease | 29 Aug 2010 |
| Collateral damage to the heart: effects of novel molecular therapies in oncology and ophtalmology | Conventional chemotherapy and cardiac side effects. | Michael Hallek (DE) | Vascular biology | 29 Aug 2010 |
| Collateral damage to the heart: effects of novel molecular therapies in oncology and ophtalmology | Anti-angiogenesis for wet age-related macular degeneration and diabetic retinopathy. | Nicolas Leveziel (FR) | Vascular biology | 29 Aug 2010 |
| Collateral damage to the heart: effects of novel molecular therapies in oncology and ophtalmology | Inhibition of tumour angiogenesis and cardiovascular side effects. | Renu Virmani (US) | Vascular biology | 29 Aug 2010 |
| Meet the Trialist I - SHIFT | SHIFT: Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction | Ian Ford (UK) | | 29 Aug 2010 |
| The new ESC Guidelines | Myocardial revascularisation (ESC/EACTS). | Philippe H Kolh (BE) | | 29 Aug 2010 |